By Sam Boughedda
Investing.com — Covid-19 related vaccine stocks have made gains Friday after concerns were raised about a new coronavirus variant in South Africa that is said to have several mutations.
With concerns being raised about the variant's potential ability to evade current vaccines, stocks such as Pfizer Inc (NYSE: PFE ), BioNTech SE (NASDAQ: BNTX ), Moderna Inc (NASDAQ: MRNA ), Inovio Pharmaceuticals Inc (NASDAQ: INO ), Novavax Inc (NASDAQ: NVAX ), Vir Biotechnology Inc (NASDAQ: VIR ), and others have surged.
Pfizer shares rose 6%. Moderna rose 23%. Inovio rose more than 8%, while Novavax shares rose more than 9%. Vir rose 16%. Meanwhile, the Dow Jones Industrial Average lost more than 2%, or 850 points, in morning trading.
According to Reuters, BioNTech said it expects further data on the new variant within the next two weeks and that if necessary, it would be able to redesign the vaccine within 6 weeks and deliver batches within 100 days.
In certain European countries, a reintroduction of lockdown restrictions has already started, with cases rising once again. In addition, while some commentators have described the variant as the "most concerning" so far, it is important to note that not much is known about it just yet, with scientists still working to understand its implications.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.